7 assets in Cannabis Dependence

Therapeutic assets addressing Cannabis Dependence, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Metformin Cannabis Dependence	Nova Scotia Health Authority	P4	BB (65)
Tirzepatide Cannabis Dependence	McMaster University	P3	B (60)
Gabapentin Cannabis Dependence	Medical University of South Carolina	P2	B (57)
Nabiximols Cannabis Dependence	University of Birmingham	P2	CCC (53)
Teonanacatl Cannabis Dependence	McMaster University	P2	CCC (53)
Delta-9-Thc Cannabis Dependence	Yale University	P1	CC (43)